You are currently viewing a new version of our website. To view the old version click .

Current Oncology, Volume 32, Issue 7

July 2025 - 44 articles

Cover Story: Patients with advanced cancer benefit from palliative care (PC) alongside curative therapy to improve their quality of life. In Ontario, Canada, cancer patients regularly complete the Edmonton Symptom Assessment System—Revised (ESAS-r) at cancer clinic visits, to quantify the severity of nine symptoms. Previous studies show that individual symptom scores can predict acute care use, and a 2023 study found that ESAS-r symptom complexity, a novel algorithm that labels patients as "low", "medium", or "high" complexity based on the number and severity of symptoms, can predict acute care use among cancer patients. Subsequently, we investigated whether this predictive association holds specifically among adult advanced cancer patients already followed by a cancer outpatient PC service. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (44)

  • Article
  • Open Access
2,658 Views
13 Pages

Gratitude journaling is a simple and effective way to improve emotional well-being. However, its impact on people with breast cancer in South Korea has not been clearly understood. This study explored how writing a gratitude journal can help patients...

  • Article
  • Open Access
1,811 Views
10 Pages

Background: Understanding patient perceptions of cancer care is crucial for improving treatment experiences and health outcomes. This study explores female patient-reported experiences with cancer care. Our aim was to identify areas for improvement a...

  • Conference Report
  • Open Access
993 Views
18 Pages

Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17–18 October 2024

  • Deepti Ravi,
  • Shahid Ahmed,
  • Blaire Anderson,
  • Brady Anderson,
  • Bryan Brunet,
  • Haji Chalchal,
  • Arun Elangovan,
  • Georgia Geller,
  • Vallerie Gordon and
  • Branawan Gowrishankar
  • + 13 authors

The 26th annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Saskatoon, Saskatchewan, on 17–18 October 2024. The WCGCCC is an interactive multidisciplinary conference that was attended by healthcare profess...

  • Review
  • Open Access
2,549 Views
17 Pages

Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences

  • Thoma’ Dario Clementi,
  • Francesca Colonese,
  • Stefania Canova,
  • Maria Ida Abbate,
  • Luca Sala,
  • Francesco Petrella,
  • Gabriele Giuseppe Pagliari and
  • Diego Luigi Cortinovis

Resectable non-small cell lung cancer (NSCLC) continues to pose significant challenges with high recurrence and mortality rates, despite traditional platinum-based chemotherapy yielding only an approximate 5% improvement in 5-year overall survival wh...

  • Article
  • Open Access
1 Citations
2,409 Views
18 Pages

Pre-Implementation Assessment of a Sexual Health eClinic in Canadian Oncology Care

  • Taylor Incze,
  • Dalia Peres,
  • Steven Guirguis,
  • Sarah E. Neil-Sztramko,
  • Jackie Bender,
  • Dean Elterman,
  • Shabbir M. H. Alibhai,
  • Antonio Finelli,
  • Phil Vu Bach and
  • Emily Belita
  • + 12 authors

Sexual dysfunction is a prevalent and often under-addressed concern among prostate cancer survivors, significantly affecting quality of life for patients and their partners. The True North Sexual Health and Rehabilitation eClinic (SHAReClinic) is a v...

  • Conference Report
  • Open Access
1,367 Views
15 Pages

Prioritizing the Timely Detection and Diagnosis of Early-Age Onset Cancer to Enable Optimal Disease Management and Outcomes

  • Michael J. Raphael,
  • Petra Wildgoose,
  • Darren Brenner,
  • Christine Brezden-Masley,
  • Ronald Burkes,
  • Robert C. Grant,
  • Alexandra Pettit,
  • Cassandra Macaulay,
  • Monika Slovinec D’Angelo and
  • Filomena Servidio-Italiano

In November 2024, the fourth annual Symposium focusing on early-age onset cancer (EAOC) was hosted by the Colorectal Cancer Resource & Action Network (CCRAN), assembling clinicians, researchers, and patients virtually to discuss challenges in ear...

  • Article
  • Open Access
1,014 Views
13 Pages

Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis

  • Alper Coskun,
  • Ahmet Bilgehan Sahin,
  • Selva Kabul,
  • Muhammed Abdurrahman Celik,
  • Mursel Sali,
  • Ender Eren Ozcelik,
  • Adem Deligonul,
  • Erdem Cubukcu,
  • Meral Kurt and
  • Gursel Savci
  • + 2 authors

Background and Objective: Bladder cancer (BC) is the ninth most common malignancy worldwide. Squamous cell carcinoma (SqCC), a rare histological variant, accounts for approximately 2–5% of all BC cases. Compared to urothelial carcinoma, the pre...

  • Article
  • Open Access
1 Citations
1,525 Views
12 Pages

This retrospective study aimed to assess the effectiveness of prophylactic hepatoprotective therapy in decreasing the incidence of drug-induced liver injury (DILI) among patients with cervical cancer undergoing chemotherapy. The analysis was performe...

  • Perspective
  • Open Access
1 Citations
2,044 Views
9 Pages

Cancer Immunotherapy: The Role of Nursing in Patient Education, Assessment, Monitoring, and Support

  • Parmis Mirzadeh,
  • Edith Pituskin,
  • Ivan Au,
  • Sheri Sneath and
  • Catriona J. Buick

The prevalence of cancer is rising both in Canada and across the world, with approximately 35 million new cases predicted by 2050. Cancer immunotherapy is a form of treatment that harnesses the body’s immune system to fight cancer cells, increa...

  • Article
  • Open Access
1,531 Views
16 Pages

Treatment-Induced Gene Expression Changes in Metastatic Renal Cell Carcinoma: Insights from a Syngeneic Mouse Model

  • Ko Okabe,
  • Toshiaki Tanaka,
  • Tetsuya Shindo,
  • Yuki Kyoda,
  • Sachiyo Nishida,
  • Kohei Hashimoto,
  • Ko Kobayashi and
  • Naoya Masumori

This study aimed to clarify the alterations in gene expression in metastatic renal cell carcinoma (mRCC) during disease progression and in response to treatment with immune checkpoint inhibitors using a syngeneic mouse mRCC model. RENCA cells were or...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729